We serve Chemical Name:methyl 2-(4-amino-3-iodophenyl)acetate CAS:374933-81-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 2-(4-amino-3-iodophenyl)acetate
CAS.NO:374933-81-0
Synonyms:i01-8667
Molecular Formula:C9H10INO2
Molecular Weight:291.08600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:52.32000
Exact Mass:290.97600
LogP:2.17010
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like i01-8667 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,i01-8667 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,i01-8667 Use and application,i01-8667 technical grade,usp/ep/jp grade.
Related News: In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. methyl 2-(4-amino-3-iodophenyl)acetate manufacturer In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. methyl 2-(4-amino-3-iodophenyl)acetate supplier In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. methyl 2-(4-amino-3-iodophenyl)acetate vendor In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. methyl 2-(4-amino-3-iodophenyl)acetate factory In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.
